Review highlights the clinical significance and challenges of managing Elizabethkingia meningoseptica in vulnerable patients, indicating urgent need for comprehensive strategies.
Elizabethkingia meningoseptica , a Gram-negative, nonfermenting bacterium, has emerged as a significant nosocomial pathogen, particularly in immunocompromised and critically ill patients. The increasing recognition of this pathogen underscores its significant impact on healthcare systems and the vulnerability of specific patient populations. Effective management of E . meningoseptica requires a coordinated multidisciplinary approach encompassing advanced diagnostics, tailored antimicrobial stewardship, and rigorous infection prevention practices. This review aims to provide an overview of its clinical significance, pathogenesis, antimicrobial resistance mechanisms, diagnostic and therapeutic challenges, and infection control measures.
No takes yet. Share an insight, caveat, or question.
Gawande et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: